test

Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma

Conditions

Brain and Central Nervous System Tumors

What is the purpose of this trial?

RATIONALE: Sometimes a tumor may not need treatment until it progresses. In this case, observation may be sufficient. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor, such as 3-dimensional conformal radiation therapy and intensity-modulated radiation therapy, may kill more tumor cells and cause less damage to normal tissue. It is not yet known whether observation is more effective than radiation therapy in treating patients with meningioma.

PURPOSE: This phase II trial is studying observation to see how well it works compared with radiation therapy in treating patients with grade I, grade II, or grade III meningioma.



Participation Guidelines

Age:
18 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
Dates:
June 2009
Last Updated:
April 6, 2011
Study HIC#:
1007007089

Clinicaltrials.gov ID: NCT00895622